117 related articles for article (PubMed ID: 12583816)
21. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
Kubota K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.
Di Seri M; De Sanctis R; Quadrini S; Adua D; Stumbo L; Del Signore E; Gori B; Grassi P; Basile ML; Longo F
J Chemother; 2011 Apr; 23(2):110-3. PubMed ID: 21571629
[TBL] [Abstract][Full Text] [Related]
23. Vinorelbine-induced pancreatitis: a case report.
Tester W; Forbes W; Leighton J
J Natl Cancer Inst; 1997 Nov; 89(21):1631. PubMed ID: 9362167
[No Abstract] [Full Text] [Related]
24. Intestinal side-effects of docetaxel/vinorelbine combination.
de Matteis A; Nuzzo F; Rossi E; Landi G; Perrone F
Lancet; 2000 Mar; 355(9209):1098-9. PubMed ID: 10744113
[No Abstract] [Full Text] [Related]
25. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
Ibrahim NK; Sahin AA; Dubrow RA; Lynch PM; Boehnke-Michaud L; Valero V; Buzdar AU; Hortobagyi GN
Lancet; 2000 Jan; 355(9200):281-3. PubMed ID: 10675076
[TBL] [Abstract][Full Text] [Related]
26. On and off metronomic oral vinorelbine in elderly women with advanced breast cancer.
De Iuliis F; Salerno G; Taglieri L; Lanza R; Scarpa S
Tumori; 2015; 101(1):30-5. PubMed ID: 25702645
[TBL] [Abstract][Full Text] [Related]
27. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
28. A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.
Lister-Sharp D; McDonagh MS; Khan KS; Kleijnen J
Health Technol Assess; 2000; 4(17):1-113. PubMed ID: 11074389
[TBL] [Abstract][Full Text] [Related]
29. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
[TBL] [Abstract][Full Text] [Related]
30. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of concurrent vinorelbine and radiation therapy in high-risk postmastectomy breast cancer patients.
Honda K; Riku M; Iwase M; Hirasawa N; Yamada T; Goto Y; Kawada K
Breast Cancer; 2016 Sep; 23(5):701-5. PubMed ID: 26206720
[TBL] [Abstract][Full Text] [Related]
32. Fatal Clostridium difficile infection associated with vinorelbine chemotherapy: case report and literature review.
Ansari J; Choo B; Fernando I
J Infect Chemother; 2010 Jun; 16(3):210-2. PubMed ID: 20198401
[TBL] [Abstract][Full Text] [Related]
33. Vinorelbine/paclitaxel combination studied in treatment of metastatic breast cancer patients.
Oncology (Williston Park); 1995 Jun; 9(6):518, 543. PubMed ID: 8719098
[No Abstract] [Full Text] [Related]
34. [Vinorelbine for non-small cell lung cancer].
Seto T
Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
[No Abstract] [Full Text] [Related]
35. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
Vokes EE
Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
[TBL] [Abstract][Full Text] [Related]
36. Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
Gralla RJ; Gatzemeier U; Gebbia V; Huber R; O'Brien M; Puozzo C
Drugs; 2007; 67(10):1403-10. PubMed ID: 17600389
[TBL] [Abstract][Full Text] [Related]
37. Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy.
Mano M
Cancer Treat Rev; 2006 Apr; 32(2):106-18. PubMed ID: 16473470
[TBL] [Abstract][Full Text] [Related]
38. Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.
Norris B; Pritchard KI; James K; Myles J; Bennett K; Marlin S; Skillings J; Findlay B; Vandenberg T; Goss P; Latreille J; Rudinskas L; Lofters W; Trudeau M; Osoba D; Rodgers A
J Clin Oncol; 2000 Jun; 18(12):2385-94. PubMed ID: 10856098
[TBL] [Abstract][Full Text] [Related]
39. Better treatments needed for breast cancer brain metastases.
Lin NU
Lancet Oncol; 2015 Dec; 16(16):1583-4. PubMed ID: 26596673
[No Abstract] [Full Text] [Related]
40. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
Jones SF; Burris HA
Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]